KRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 25, 2021 in the Class Action Filed on Behalf of Repro Med Systems, Inc. Limited Shareholders

New York, New York--(Newsfile Corp. - May 25, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Repro Med Systems, Inc. (NASDAQ: KRMD) alleging that the Company violated federal securities laws.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7092/85197_479123_logo.jpg

Class Period: August 4, 2020 and January 25, 2021
Lead Plaintiff Deadline: May 25, 2021

Learn more about your recoverable losses in KRMD:
http://www.kleinstocklaw.com/pslra-1/repro-med-systems-inc-loss-submission-form?id=16166&from=5

The filed complaint alleges that Repro Med Systems, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) starting in January 2020, Repro Med Systems ramped up the use of allowances, including growth rebates, to retain key customers and to incentivize growth; (2) as the rebates accrued, the Company's net sales were reasonably likely to decline; and (3) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Shareholders have until May 25, 2021 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

For additional information about the KRMD lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click the link above.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/85197

info